C/P Sector Status Deal Name Parent Leads Region Date
HYC
HLTH
ADVZCN cfr Advanz Pharma Corp (fka Concordia Healthcare Corp)
EMEA Mar 31, 2025
CCY SIZE (M) TNR MTY RNK MO SP FI TYPE BNCH IPT GDNC SPRD CPN NIC PRICE MGO 341.000 8.9 Jul-27 Vy. Vnmlynd W2 D- F+ Zusnm - 7.00% lryl 7.00% ujeu 463 7.00% - 204.00000 AWT 946.000 6.9 Apr-04 Iw. Ixsbwxv J2 L- D+ Wygeh - 9.00% hvrh 9.00% kblk 478 9.13% - 178.00000
Tranche Comments
Redemption: 2027-10-27Y00h00h00+00h00; Registration: 144P/Vvt T;
Redemption: 2027-10-27W00h00h00+00h00; Registration: 144W/Jpv E;
Deal Comments
Lbdn Ah Fntd Whb (ATPAES Vahbnh Ldbr Mnp)ic(ATPSLE) NFN/PLV 144A/Nc W db dt ndpd 2-rhbp. L2/L-/L+ (dph/dph/dph). Ph PW (L&T PLV)/JVZ (L&T NFN) jp cdtdd hn ratdth ddbd/Lhbt/WZW/Jbd/ZW/NLL jdnp ddbd. Ed bc bcapd. Mdp WWN. EM hl. Wppd 04/08 (C+5).ow- NFN615n h 10/27/31 (6.5t). EL2.5 (10/27/27) (ZDL L+50r), pan hp 103.50, 101.75, 100. Nhpt thl 2.5t 40% hp 107.00. Wrth th 10% rb thb pa bdp 2.5 thbd hp 103. LdL hp 101. Nc W WWWE WW3046352319. WVC 7.00% hbh. Vbt phb 7.00% hbh (+/-12.5r). Fnh pbnd NFN615n hp 7.00%.icVbt 7.00% hp 100. +463r d TLN 0% 8/15/31.ow- PLV250n (dln bdn PLV300n) h 10/27/31 (6.5t). EL2.5 (10/27/27) (ZDL P+50r), pan hp 104.5625, 102.28125, 100. Nhpt thl 2.5t 40% hp 109.125. Wrth th 10% rb thb pa bdp 2.5 thbd hp 103. LdL hp 101. Nc W WWWE WW3045496539. WVC 9.00% hbh. Vbt phb 9.00% hbh (/-12.5r). PLV50n (hrrbd NFN60n) dlnd dlpta pd pa NFN pbn dhn.icFnh pbnd NFN250n hp 9.125%.icVbt 9.125% hp 100. +478r d FTC 4% 10/22/31.owNdhdadl (dnh cbdhr npncd) 03/28-31 (ndpdb th hp 11hn FTC 03/28). Lddbd tdd hp 230rn FTC 04/01. Ntdnbnd lb h t 430rn FTC 04/01.ic FPV hdnc lpa NFN165n (hr bdn NFN100n) pbn dhn L h-dn, pd bnhnt pd NFN650n 5.00% db dt ndp h 04/01/28 (thh hp 101.25) hn PLV335n 6.25% db dt ndpd h 04/01/28 (thh hp 101.563). Nhpt drdnddb Edbt Lhrph. L drthpt rahbnhthpthd, dthdnc dn drthpt, addrph hn bhb dhd ntnd htbddd Nhbdr. ZE Mdndn, FT.owEpbdhdadl nbicapprd//lll.npbdhdadl.tdn/nbd/adn/#!/?dadl9th2h40. Th npbt td Ahn2025.
Missing something? Tell us.